-

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Xponential Fitness, Inc. (XPOF)

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming April 9, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Xponential Fitness, Inc. (“Xponential” or the “Company”) (NYSE: XPOF) Class A common stock between July 26, 2021 and December 7, 2023, inclusive (the “Class Period”).

If you suffered a loss on your Xponential investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at www.glancylaw.com/cases/Xponential-Fitness-Inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

On June 26, 2023, Fuzzy Panda Research published a report alleging, among other things, that Xponential is “hiding the fact that many of their brands and franchisees are struggling.” The report further alleges that, despite CEO claims that the Company has “never closed a store,” Fuzzy Panda found over 30 permanently closed stores. Fuzzy Panda also claims that franchise documents suggest that 8 out of every 10 Xponential brands are losing money monthly, with over half of Xponential studios never making a positive financial return.

On this news, Xponential’s stock price fell $9.39, or 37.4%, to close at $15.72 per share on June 27, 2023, thereby injuring investors.

Then, on December 7, 2023, Bloomberg Businessweek published an article stating that interviews with former business partners, employees, and franchisees of Xponential revealed that the Company misled many franchisees into a “financial nightmare.” The article further alleged that “many of the company’s franchisees . . . have either declared bankruptcy or [lost] their retirement savings.”

On this news, Xponential’s stock price fell $1.61, or 15.2%, to close at $8.99 per share on December 11, 2023, thereby injuring investors further.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Xponential had permanently closed at least 30 stores; (2) that Xponential’s reported SSS and AUV metrics had been misstated by excluding underperforming stores; (3) that 8 out of 10 Xponential brands were losing money monthly; (4) that over 50% of Xponential studios did not make a positive financial return; (5) that over 60% of Xponential’s revenue was one-time and nonrecurring; (6) that more than 100 of the Company’s franchises were for sale at a price that is at least 75% less than their initial cost; (7) that Xponential had misled many of its franchisees into opening franchises by misrepresenting the financial profile and profitability of its studios, as well as the expected rate of return for new studio openings; (8) that many Xponential franchisees were substantially in debt, suffering high attrition rates and running non-viable studios that had no realistic path to profitability; and (9) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Follow us for updates on LinkedIn, Twitter, or Facebook.

If you purchased or otherwise acquired Xponential common stock during the Class Period, you may move the Court no later than April 9, 2024 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com

Glancy Prongay & Murray LLP

NYSE:XPOF

Release Versions

Contacts

Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com

More News From Glancy Prongay & Murray LLP

GO CLASS ACTION NOTICE: Glancy Prongay Wolke & Rotter LLP Files Securities Fraud Lawsuit On Behalf Of Grocery Outlet Holding Corp. Investors

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP (“GPWR”), announces that it has filed a class action lawsuit in the United States District Court for the Northern District of California, captioned Jones v. Grocery Outlet Holding Corp., et al., Case No. 3:26-cv-02291, on behalf of persons and entities that purchased or otherwise acquired Grocery Outlet Holding Corp. (“Grocery Outlet” or the “Company”) (NASDAQ: GO) securities between August 5, 2025 and March 4, 2026, inclusive...

Deadline Alert: Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 5, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ: SLNO) common stock between March 26, 2025 and November 4, 2026, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR SOLENO INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING...

Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Trip.com Group Limited (TCOM) Shareholders To Inquire About Securities Fraud Class Action

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Trip.com Group Limited (“Trip.com” or the “Company”) (NASDAQ: TCOM) securities between April 30, 2024 and January 13, 2026, inclusive (the “Class Period”). Trip.com investors have until May 11, 2026 to file a lead plaintiff motion. IF YOU SUFFERED A LOS...
Back to Newsroom